Penile Neoplasms
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Neoplasms
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Hansenula Polymorpha) for penile neoplasms | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Cemiplimab for penile neoplasms | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Chemotherapy TIP for penile neoplasms | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Partial or total penectomy with inguinal and/or pelvic lymph node dissection + PEMBROLIZUMAB + PYRUVATE CARBOXYLASE, MITOCHONDRIAL for penile neoplasms | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PUCOTENLIMAB + Becotatug Vedotin for penile neoplasms | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.